Agenda-setting intelligence, analysis and advice for the global fashion community.
CVS Health Corp. is planning to spin off its retail pharmacy business, according to media reports, in what would be one of the biggest-ever breakups in the healthcare industry.
The pharmacy business would separate from the company’s Aetna insurance unit and Caremark pharmacy benefits division, the Financial Times first reported Tuesday, citing unnamed people familiar with the matter. The Wall Street Journal later reported that the split will occur in the first half of 2028, citing the company.
CVS representatives didn’t respond to requests for comment about the reports.
The move would mark the end of an era for a company that grew from a single store in Lowell, Massachusetts, into a healthcare powerhouse with a market value of $117 billion. Although CVS has closed hundreds of stores in recent years, it still operates almost 9,000 retail pharmacies, even as rivals like Walgreens and Rite Aid struggled to compete.
ADVERTISEMENT
CVS shares rose as much as 3.7 percent in after-hours trading. The stock had climbed 15 percent this year through Tuesday’s close.
The company reviewed strategic options including a breakup in 2024, Bloomberg reported at the time. Chief Executive Officer David Joyner, who took over two years ago, has made progress in turning around the business after the Aetna segment faltered badly in recent years.
Healthcare conglomerates have faced growing political pressure over their reach into different businesses, with some state and federal lawmakers proposing to break them up. A CVS split would follow a decade-long trend of consolidation, with health insurers combining with pharmacy benefits firms and medical providers. The structure can allow companies to turn some of their expenses — to dispense medications or deliver care — into revenue for other parts of their business.
At the same time, retail drugstores face long-term challenges from online retailers. CVS is the only one of its major healthcare competitors to have a large pharmacy chain footprint. The pharmacy and consumer wellness segment generated over $139 billion in revenue last year, about a third of CVS’ total, though the company reports significant overlap in sales between its businesses.
Michael Cherny, an analyst at Leerink Partners, said reports of a breakup came as “a complete shock,” since the pharmacy and consumer wellness business has been performing well recently.
“In this context, perhaps the outlook for a standalone retail pharmacy (still with meaningful scale and leverage on its own) is stronger now than before,” Cherny wrote in a research note. “The rationale could also be to avoid what has been relentless state legislative scrutiny over the company’s level of vertical integration.”
The Wall Street Journal said Joyner will continue to run one of the companies. Some of the company’s healthcare provider assets, including Oak Street Health and Signify Health, will stay with the insurer entity, as would its specialty pharmacy. CVS’ MinuteClinics and mail-order pharmacy would be separated into the other entity, the paper said.
By John Tozzi
ADVERTISEMENT
Learn more:
Why Drugstore Beauty Is Succeeding Everywhere Except the US
Within a crowded beauty market, US drugstores are struggling to compete — while their overseas counterparts continue to thrive. To regain relevance and bring success home, American chains must evolve.

